The case between AlexSam and MasterCard brings to light critical insights into the drafting and understanding of licensing agreements and covenants not to sue.
A landmark ruling reaffirms the government's broad licensing rights under the Bayh-Dole Act in a pivotal Alzheimer’s research patent case.
The Federal Circuit's remand to USPTO in an antibody case marks a pivotal moment for written description standards in biotech.
Exploring the UK Supreme Court's ruling on AI as inventors in the landmark DABUS case and its broader implications.
